Aoxing Pharmaceutical Company is Pharmaceuticals in United States that focus on Pharmaceutical Co Inc business. They cover business area such as Aoxing Pharmaceutical Co Inc, research, development, manufacturing, distribution, pain-management, addiction treatment pharmaceutical product, aoxing, OTC, API, all its revenue, China.
-
Pharmaceutical Co Inc
-
444 Washington Boulevard
Suite 3338
Jersey City, NJ 07310
United States
Private
Aoxing Pharmaceutical Co Incresearchdevelopmentmanufacturingdistributionpain-managementaddiction treatment pharmaceutical productaoxingOTCAPIall its revenueChina
* We use standard office opening hours in near Aoxing Pharmaceutical Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aoxing Pharmaceutical Company is Pharmaceuticals business from United States that founded in - ( years old in ), Aoxing Pharmaceutical Company business is focusing on Pharmaceutical Co Inc.
Aoxing Pharmaceutical Company headquarter office and corporate office address is located in 444 Washington Boulevard Suite 3338 Jersey City, NJ 07310 United States.
Aoxing Pharmaceutical Company was founded in United States.
In , Aoxing Pharmaceutical Company is currently focus on Pharmaceutical Co Inc sector.
Above is snippet of Google Trends for "Pharmaceutical Co Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aoxing Pharmaceutical Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.